| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.71e-05 | 6 | 192 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.71e-05 | 6 | 192 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.73e-05 | 8 | 192 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 9.99e-05 | 10 | 192 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.74e-04 | 3 | 192 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | L-glutamate uniporter activity | 2.74e-04 | 3 | 192 | 2 | GO:0140788 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 3.66e-04 | 15 | 192 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ADAM23 ITGAD ITGAX JUP BMPR2 PTPRJ HSPA1A HSPA8 FN1 ITGA10 CTNND1 CDH4 TNXB CDH7 CDH12 | 7.07e-04 | 599 | 192 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 8.84e-04 | 20 | 192 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 9.02e-04 | 5 | 192 | 2 | GO:0022810 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 9.02e-04 | 5 | 192 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 MCM4 CHD2 DNAH14 MYO5C ACSL1 SUPV3L1 HSPA1A HSPA1B HSPA8 DNAH10 ATP13A5 BTAF1 MSH3 ATP4A | 9.08e-04 | 614 | 192 | 15 | GO:0140657 |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRG2 ADGRB3 CLSTN2 PLXND1 ADGRE2 JUP PTPRJ WNT3A NR1H4 ADGRL3 CUX2 FN1 DOCK7 LRP4 PATJ CDH4 CDH7 CDH12 | 5.32e-06 | 569 | 189 | 18 | GO:0034329 |
| GeneOntologyCellularComponent | catenin complex | 1.05e-05 | 32 | 193 | 5 | GO:0016342 | |
| Domain | ARM-type_fold | TOGARAM1 LYST NCDN JUP TANGO6 COPG1 BTAF1 THADA INF2 ELMO2 IQCB1 CTNND1 STKLD1 SYMPK | 1.08e-05 | 339 | 191 | 14 | IPR016024 |
| Domain | N-SET | 1.04e-04 | 2 | 191 | 2 | PF11764 | |
| Domain | N-SET | 1.04e-04 | 2 | 191 | 2 | SM01291 | |
| Domain | COMPASS_Set1_N-SET | 1.04e-04 | 2 | 191 | 2 | IPR024657 | |
| Domain | Cadherin_C | 1.13e-04 | 25 | 191 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.13e-04 | 25 | 191 | 4 | IPR000233 | |
| Domain | Spy1 | 1.64e-04 | 11 | 191 | 3 | PF11357 | |
| Domain | Speedy | 1.64e-04 | 11 | 191 | 3 | IPR020984 | |
| Domain | Catenin_binding_dom | 2.06e-04 | 29 | 191 | 4 | IPR027397 | |
| Domain | - | 2.06e-04 | 29 | 191 | 4 | 4.10.900.10 | |
| Domain | VWA | 2.66e-04 | 56 | 191 | 5 | PF00092 | |
| Domain | - | 3.10e-04 | 3 | 191 | 2 | 4.10.1130.10 | |
| Domain | GPS | 3.87e-04 | 34 | 191 | 4 | SM00303 | |
| Domain | GPS | 4.33e-04 | 35 | 191 | 4 | PF01825 | |
| Domain | ARM-like | TOGARAM1 JUP TANGO6 COPG1 BTAF1 ELMO2 IQCB1 CTNND1 STKLD1 SYMPK | 4.78e-04 | 270 | 191 | 10 | IPR011989 |
| Domain | GPS | 4.83e-04 | 36 | 191 | 4 | PS50221 | |
| Domain | Post-SET_dom | 5.34e-04 | 16 | 191 | 3 | IPR003616 | |
| Domain | PostSET | 5.34e-04 | 16 | 191 | 3 | SM00508 | |
| Domain | HSP70 | 5.34e-04 | 16 | 191 | 3 | PF00012 | |
| Domain | POST_SET | 5.34e-04 | 16 | 191 | 3 | PS50868 | |
| Domain | GPS | 5.38e-04 | 37 | 191 | 4 | IPR000203 | |
| Domain | VWF_A | 5.39e-04 | 99 | 191 | 6 | IPR002035 | |
| Domain | HSP70_2 | 6.44e-04 | 17 | 191 | 3 | PS00329 | |
| Domain | HSP70_1 | 6.44e-04 | 17 | 191 | 3 | PS00297 | |
| Domain | HSP70_3 | 6.44e-04 | 17 | 191 | 3 | PS01036 | |
| Domain | Integrin_alpha-2 | 7.67e-04 | 18 | 191 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 7.67e-04 | 18 | 191 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 7.67e-04 | 18 | 191 | 3 | PF08441 | |
| Domain | Integrin_alpha | 7.67e-04 | 18 | 191 | 3 | IPR000413 | |
| Domain | Hsp_70_fam | 7.67e-04 | 18 | 191 | 3 | IPR013126 | |
| Domain | SET | 7.98e-04 | 41 | 191 | 4 | PF00856 | |
| Domain | Int_alpha | 9.04e-04 | 19 | 191 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 9.04e-04 | 19 | 191 | 3 | IPR013519 | |
| Domain | NUT | 1.02e-03 | 5 | 191 | 2 | IPR024310 | |
| Domain | NUT_N | 1.02e-03 | 5 | 191 | 2 | IPR024309 | |
| Domain | PHR | 1.02e-03 | 5 | 191 | 2 | IPR012983 | |
| Domain | NUT | 1.02e-03 | 5 | 191 | 2 | PF12881 | |
| Domain | dCMP_cyt_deam_1 | 1.02e-03 | 5 | 191 | 2 | PF00383 | |
| Domain | PHR | 1.02e-03 | 5 | 191 | 2 | PF08005 | |
| Domain | Mab-21-like_1/2 | 1.02e-03 | 5 | 191 | 2 | IPR020950 | |
| Domain | CADHERIN_1 | 1.08e-03 | 113 | 191 | 6 | PS00232 | |
| Domain | Cadherin | 1.08e-03 | 113 | 191 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.13e-03 | 114 | 191 | 6 | PS50268 | |
| Domain | - | 1.13e-03 | 114 | 191 | 6 | 2.60.40.60 | |
| Domain | CA | 1.18e-03 | 115 | 191 | 6 | SM00112 | |
| Domain | SET | 1.24e-03 | 46 | 191 | 4 | SM00317 | |
| Domain | Cadherin-like | 1.24e-03 | 116 | 191 | 6 | IPR015919 | |
| Domain | Cadherin | 1.35e-03 | 118 | 191 | 6 | IPR002126 | |
| Domain | FG_GAP | 1.40e-03 | 22 | 191 | 3 | PS51470 | |
| Domain | VWFA | 1.53e-03 | 82 | 191 | 5 | PS50234 | |
| Domain | SET_dom | 1.69e-03 | 50 | 191 | 4 | IPR001214 | |
| Domain | 7tm_2 | 1.69e-03 | 50 | 191 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.69e-03 | 50 | 191 | 4 | PS00650 | |
| Domain | SET | 1.69e-03 | 50 | 191 | 4 | PS50280 | |
| Domain | VWA | 1.71e-03 | 84 | 191 | 5 | SM00327 | |
| Domain | FG-GAP | 1.82e-03 | 24 | 191 | 3 | PF01839 | |
| Domain | FG-GAP | 1.82e-03 | 24 | 191 | 3 | IPR013517 | |
| Domain | Integrin_dom | 2.05e-03 | 25 | 191 | 3 | IPR032695 | |
| Domain | - | 2.08e-03 | 222 | 191 | 8 | 1.25.10.10 | |
| Domain | Rho_GTPase_activation_prot | 2.09e-03 | 88 | 191 | 5 | IPR008936 | |
| Domain | CUT | 2.11e-03 | 7 | 191 | 2 | PS51042 | |
| Domain | CUT | 2.11e-03 | 7 | 191 | 2 | PF02376 | |
| Domain | CUT_dom | 2.11e-03 | 7 | 191 | 2 | IPR003350 | |
| Domain | CUT | 2.11e-03 | 7 | 191 | 2 | SM01109 | |
| Domain | - | 2.32e-03 | 333 | 191 | 10 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.42e-03 | 335 | 191 | 10 | IPR015943 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 4.45e-05 | 121 | 150 | 8 | M39823 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 6.22e-05 | 40 | 150 | 5 | MM15060 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 SETD1A EPPK1 ZNF585A SETD1B TMEM8B MED14 PLXND1 EXTL3 LYST GGT7 TYK2 KMT2C FZR1 CACNA1H MED13 ANKRD13D BTAF1 NUP214 CFAP43 THADA ARAP3 INF2 NEK8 SCARB1 LRP4 SYMPK | 1.52e-10 | 1105 | 195 | 27 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 SUSD6 ARSK PLXND1 EXTL3 ADGRE2 DDB1 GGT7 JUP BMPR2 PTPRJ OSBPL9 TANGO6 CACNA2D1 FAT4 NPR1 B4GAT1 POMT1 SELENON LRRC8D ERLIN1 KHSRP THADA STRAP SCARB1 LRP4 SYMPK | 9.35e-10 | 1201 | 195 | 27 | 35696571 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TMEM8B CHD2 ADGRV1 NCDN DNAH14 TYK2 KMT2C BMPR2 PTPRJ SUPT6H KCNMA1 OSBPL9 CACNA1H BTAF1 PATL1 POMT1 SELENON LRRC8D NCS1 THADA INF2 SH3PXD2A SLC16A14 SCARB1 CTNND1 PATJ ADAT2 CUX1 EXOC4 | 5.40e-09 | 1489 | 195 | 29 | 28611215 |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 1.42e-08 | 6 | 195 | 4 | 15963462 | |
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 7.62e-08 | 20 | 195 | 5 | 7806582 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 23352621 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.74e-07 | 3 | 195 | 3 | 15129916 | |
| Pubmed | Negative Regulation of IKKε-Mediated IRF7 Phosphorylation by HSP70. | 1.74e-07 | 3 | 195 | 3 | 32169844 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 28025138 | ||
| Pubmed | 3.07e-07 | 11 | 195 | 4 | 31073027 | ||
| Pubmed | SETD1A MED14 KMT2C JUP NUFIP2 OSBPL9 RFX1 KHSRP STRAP DOCK7 CTNND1 PATJ CUX1 EXOC4 SYMPK | 5.69e-07 | 549 | 195 | 15 | 38280479 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SEH1L SETD1A SETD1B MCM4 CHD2 DDB1 ACSL1 JUP SUPV3L1 AHCY POLR1B HSPA8 FN1 RNF31 COPG1 MSH3 NUP214 ERLIN1 KHSRP ACTR1B ARAP3 INF2 CTNND1 EXOC4 | 6.83e-07 | 1353 | 195 | 24 | 29467282 |
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 6.91e-07 | 4 | 195 | 3 | 18299791 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 6.91e-07 | 4 | 195 | 3 | 22956628 | |
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 18379898 | ||
| Pubmed | JUP HSPA1A HSPA1B TANGO6 DRG2 POLH NUP214 INPP5F RFX1 RBM20 DOCK7 CUX1 EXOC4 | 7.92e-07 | 418 | 195 | 13 | 34709266 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SEH1L SETD1A SETD1B MED14 MCM4 SUPT6H NUFIP2 POLR1B RAE1 NUP214 LSM12 ACTR6 CTNND1 | 1.40e-06 | 440 | 195 | 13 | 34244565 |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 1.72e-06 | 5 | 195 | 3 | 11584023 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 1.72e-06 | 5 | 195 | 3 | 16906134 | |
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 17182002 | ||
| Pubmed | 2.76e-06 | 18 | 195 | 4 | 23042605 | ||
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 3.43e-06 | 6 | 195 | 3 | 7988674 | |
| Pubmed | 3.43e-06 | 6 | 195 | 3 | 9305631 | ||
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 3.43e-06 | 6 | 195 | 3 | 25281747 | |
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 3.43e-06 | 6 | 195 | 3 | 11032181 | |
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 5.98e-06 | 7 | 195 | 3 | 10205060 | |
| Pubmed | The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). | 5.98e-06 | 7 | 195 | 3 | 12370829 | |
| Pubmed | 5.98e-06 | 7 | 195 | 3 | 10556287 | ||
| Pubmed | 8.18e-06 | 236 | 195 | 9 | 36339263 | ||
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 9.33e-06 | 24 | 195 | 4 | 25126785 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 9.52e-06 | 8 | 195 | 3 | 9122205 | |
| Pubmed | 9.52e-06 | 8 | 195 | 3 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 9.52e-06 | 8 | 195 | 3 | 23130995 | |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | PDGFRA PDK3 FAM98B DDB1 JUP HSPA1A HSPA1B SCML4 LSM12 SH3PXD2A CTNND1 TMEM19 | 1.08e-05 | 453 | 195 | 12 | 27113764 |
| Pubmed | ARHGAP32 SEC24A MCM4 DDB1 JUP NUFIP2 AHCY HSPA1B HSPA8 NUP214 ERLIN1 DOCK7 CTNND1 PATJ EXOC4 | 1.24e-05 | 708 | 195 | 15 | 39231216 | |
| Pubmed | 1.30e-05 | 26 | 195 | 4 | 19749747 | ||
| Pubmed | 1.42e-05 | 9 | 195 | 3 | 22665483 | ||
| Pubmed | Ulk4, a Newly Discovered Susceptibility Gene for Schizophrenia, Regulates Corticogenesis in Mice. | 1.42e-05 | 9 | 195 | 3 | 34235142 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 1.42e-05 | 9 | 195 | 3 | 36272447 | |
| Pubmed | 1.42e-05 | 9 | 195 | 3 | 21763498 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SETD1A EPPK1 MCM4 CHD2 DDB1 HSPA1A HSPA8 MSH3 ACTR6 CUX1 EXOC4 | 1.56e-05 | 394 | 195 | 11 | 27248496 |
| Pubmed | 1.85e-05 | 329 | 195 | 10 | 35562734 | ||
| Pubmed | PIK3AP1 KNTC1 DDB1 GGT7 NUFIP2 POLR1B DRG2 DGKE NUP214 PATL1 LSM12 STRAP IQCB1 CTNND1 PATJ | 1.86e-05 | 733 | 195 | 15 | 34672954 | |
| Pubmed | MED14 MCM4 DDB1 NCDN ACSL1 SUPT6H COPG1 MSH3 RFX1 ELMO2 NNT EXOC4 SYMPK | 1.87e-05 | 560 | 195 | 13 | 35241646 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 2.02e-05 | 10 | 195 | 3 | 11932435 | |
| Pubmed | 2.02e-05 | 10 | 195 | 3 | 12832005 | ||
| Pubmed | 2.02e-05 | 10 | 195 | 3 | 7906708 | ||
| Pubmed | 2.02e-05 | 10 | 195 | 3 | 23921388 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 2.04e-05 | 29 | 195 | 4 | 15203201 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 2.04e-05 | 29 | 195 | 4 | 22036570 | |
| Pubmed | 2.09e-05 | 99 | 195 | 6 | 19730683 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.52e-05 | 341 | 195 | 10 | 32971831 | |
| Pubmed | 2.52e-05 | 272 | 195 | 9 | 31010829 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | SEH1L MCM4 ADGRV1 BTBD1 DDB1 AHCY HSPA1A HSPA8 COPG1 BTBD2 KHSRP STRAP | 2.58e-05 | 495 | 195 | 12 | 28581483 |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.68e-05 | 31 | 195 | 4 | 20516061 | |
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 2.77e-05 | 11 | 195 | 3 | 27708256 | |
| Pubmed | 2.77e-05 | 11 | 195 | 3 | 24318877 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 3.13e-05 | 2 | 195 | 2 | 12411538 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 2868009 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 16986166 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 25059644 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 3.13e-05 | 2 | 195 | 2 | 24328534 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 3786141 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 7813466 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 3.13e-05 | 2 | 195 | 2 | 26923070 | |
| Pubmed | BK Potassium Channels Suppress Cavα2δ Subunit Function to Reduce Inflammatory and Neuropathic Pain. | 3.13e-05 | 2 | 195 | 2 | 29466724 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 18212744 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 9598326 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 3.13e-05 | 2 | 195 | 2 | 11864979 | |
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 3.13e-05 | 2 | 195 | 2 | 11448776 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 15719414 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 26976620 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 3.13e-05 | 2 | 195 | 2 | 21187371 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 35581205 | ||
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 3.13e-05 | 2 | 195 | 2 | 20430459 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 3.13e-05 | 2 | 195 | 2 | 20876613 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 20223214 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 3.13e-05 | 2 | 195 | 2 | 23704948 | |
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 3.13e-05 | 2 | 195 | 2 | 2858050 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 3.13e-05 | 2 | 195 | 2 | 12207910 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 28837204 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 29572464 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 15988927 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 26448330 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 12714332 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 19299581 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 3.13e-05 | 2 | 195 | 2 | 33526815 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 11713291 | ||
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 3.13e-05 | 2 | 195 | 2 | 21108992 | |
| Pubmed | Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes. | 3.13e-05 | 2 | 195 | 2 | 23626738 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 27822537 | ||
| Pubmed | Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). | 3.13e-05 | 2 | 195 | 2 | 31320473 | |
| Pubmed | Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia. | 3.13e-05 | 2 | 195 | 2 | 19996107 | |
| Pubmed | Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions. | 3.13e-05 | 2 | 195 | 2 | 12114509 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 16971451 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 29631603 | ||
| Interaction | TOP3B interactions | ABCC3 SETD1A EPPK1 ZNF585A SETD1B TMEM8B SEC24A MED14 PLXND1 EXTL3 LYST GGT7 TYK2 KMT2C FZR1 NUFIP2 CACNA1H MED13 ANKRD13D BTAF1 MSH3 NUP214 PATL1 CFAP43 LSM12 ACTR1B THADA ARAP3 STRAP INF2 NEK8 SCARB1 LRP4 EXOC4 SYMPK | 3.63e-07 | 1470 | 191 | 35 | int:TOP3B |
| Interaction | SCGB1D4 interactions | 4.94e-06 | 27 | 191 | 5 | int:SCGB1D4 | |
| Cytoband | 7q22.1 | 9.42e-06 | 113 | 195 | 6 | 7q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 4.56e-05 | 219 | 195 | 7 | chr7q22 | |
| Cytoband | 9q34.1 | 6.95e-05 | 19 | 195 | 3 | 9q34.1 | |
| Cytoband | 12q23.1 | 3.75e-04 | 33 | 195 | 3 | 12q23.1 | |
| Cytoband | 12q24.31 | 3.88e-04 | 80 | 195 | 4 | 12q24.31 | |
| Cytoband | 10q22.3 | 8.22e-04 | 43 | 195 | 3 | 10q22.3 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 8.72e-05 | 12 | 136 | 3 | 756 | |
| GeneFamily | Heat shock 70kDa proteins | 2.62e-04 | 17 | 136 | 3 | 583 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.13e-04 | 18 | 136 | 3 | 1160 | |
| GeneFamily | Nucleoporins | 1.76e-03 | 32 | 136 | 3 | 1051 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.95e-03 | 9 | 136 | 2 | 527 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.10e-03 | 34 | 136 | 3 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.43e-03 | 10 | 136 | 2 | 830 | |
| GeneFamily | WD repeat domain containing | 3.71e-03 | 262 | 136 | 7 | 362 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.12e-03 | 43 | 136 | 3 | 409 | |
| GeneFamily | CD molecules|Type II classical cadherins | 4.15e-03 | 13 | 136 | 2 | 1186 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | ADAMTS19 PRR5L PDGFRA SUSD6 IRF1 IRF7 ADGRV1 ITIH3 RNF31 RASA4 | 2.73e-06 | 200 | 195 | 10 | M7807 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | GABRG2 CLSTN2 LYST NCDN JUP KCNMA1 GRIN3A NYAP1 SLC17A6 DGKE SLC4A3 SH3PXD2A SLC16A14 CDH4 MAB21L1 | 6.45e-06 | 506 | 195 | 15 | M39067 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | PIK3AP1 GALK2 IRF1 PLXND1 ADGRE2 TYK2 ACSL1 PTPRJ DRG2 SH3PXD2A SCARB1 PAFAH2 SERPINB1 CUX1 | 8.93e-06 | 456 | 195 | 14 | M2094 |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 1.50e-05 | 71 | 195 | 6 | M12482 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 1.91e-05 | 74 | 195 | 6 | MM768 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 2.01e-05 | 200 | 195 | 9 | M5915 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 4.68e-05 | 10 | 195 | 3 | MM1243 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | GALK2 PRR5L MED14 ADGRV1 ST3GAL6 SIMC1 POLR1B HSPA1A HSPA1B HSPA8 MED13 TANGO6 TICRR CACNA2D1 POT1 MSH3 NUP214 LRRC8D RBM20 LRP4 CDH4 CUX1 | 1.67e-06 | 779 | 188 | 22 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#3_top-relative-expression-ranked_500 | 1.11e-05 | 57 | 188 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_500 | PRR5L ST3GAL6 SIMC1 HSPA1A HSPA8 MED13 TANGO6 CACNA2D1 POT1 MSH3 NUP214 LRP4 CDH4 CUX1 | 1.44e-05 | 401 | 188 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | PIK3AP1 ITGAX BMPR2 ZFYVE9 PTPRJ HSPA1A HSPA1B HGSNAT INPP5F LRRC8D ELMO2 SCARB1 DOCK7 CTNND1 | 1.48e-05 | 402 | 188 | 14 | GSM605883_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | PRR5L IRF7 PLXND1 ITGAX ZFYVE9 PTPRJ HSPA1A HSPA1B FN1 RASA4 ELMO2 SCARB1 DOCK7 CTNND1 | 1.74e-05 | 408 | 188 | 14 | GSM605868_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.77e-05 | 166 | 188 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | PRR5L IRF7 PLXND1 ITGAX ZFYVE9 PTPRJ HSPA1A HSPA1B FN1 RASA4 ELMO2 SCARB1 DOCK7 CTNND1 | 1.99e-05 | 413 | 188 | 14 | GSM605878_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | PIK3AP1 PRR5L ITGAX BMPR2 ZFYVE9 PTPRJ HSPA1A HSPA1B INPP5F LRRC8D ELMO2 SCARB1 DOCK7 | 6.10e-05 | 400 | 188 | 13 | GSM605886_500 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | ABCC3 PRR5L ZNF585A ADGRB3 MCM4 CLSTN2 PLXND1 ST3GAL6 SIMC1 GRIN3A HSPA8 ADGRL3 TANGO6 CACNA2D1 CUX2 RBM20 NCS1 PATJ CDH4 CUX1 | 7.50e-05 | 855 | 188 | 20 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ARHGAP32 PRR5L ARSK MED14 BACE1 MYO5C ST3GAL6 HSPA1B MED13 CACNA2D1 CUX2 POT1 MSH3 NUP214 LRRC8D SLC15A2 PATJ CUX1 | 1.87e-04 | 774 | 188 | 18 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | EPPK1 TYK2 RASA4B CACNA1H SPDYE2B FN1 RASA4 SPDYE2 ADAT2 SPDYE6 | 2.12e-04 | 281 | 188 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | EPPK1 TYK2 RASA4B CACNA1H SPDYE2B FN1 RASA4 SPDYE2 ADAT2 SPDYE6 | 2.12e-04 | 281 | 188 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.16e-04 | 181 | 188 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 2.23e-04 | 137 | 188 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | ABCC3 ARHGAP32 ADAM23 ITGAD ITGAX JUP ZFYVE9 PTPRJ ADGRL3 SCARB1 DOCK7 CTNND1 | 2.63e-04 | 403 | 188 | 12 | GSM605853_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | SETD1B ADAM23 GRIN3A MED13 ADGRL3 CACNA2D1 FAT4 CUX2 NUP214 SLC15A2 MAB21L1 CUX1 | 2.88e-04 | 407 | 188 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000 | ARHGAP32 PRR5L MCM4 CLSTN2 ST3GAL6 SIMC1 MSH3 RBM20 NCS1 CDH4 | 2.96e-04 | 293 | 188 | 10 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k4 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | PIK3AP1 PRR5L ITGAX ZFYVE9 PTPRJ FN1 HGSNAT LRRC8D RASA4 ELMO2 SCARB1 SERPINB1 | 3.01e-04 | 409 | 188 | 12 | GSM854332_500 |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | ADAM23 PLXND1 ITGAX BMPR2 ZFYVE9 PTPRJ HSPA1A HSPA1B NPR1 FN1 DOCK7 CTNND1 | 3.14e-04 | 411 | 188 | 12 | GSM538239_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.28e-04 | 146 | 188 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-07 | 179 | 195 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-07 | 188 | 195 | 9 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD14|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 200 | 195 | 9 | 54221271becd02a4ffa826e06c8e76fcd2651d50 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.13e-06 | 176 | 195 | 8 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-06 | 181 | 195 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-06 | 188 | 195 | 8 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-06 | 194 | 195 | 8 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.52e-06 | 196 | 195 | 8 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 196 | 195 | 8 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 2.61e-06 | 197 | 195 | 8 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.61e-06 | 197 | 195 | 8 | 3b71e523d8a68f131def17233385df371db70db5 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 197 | 195 | 8 | e862561f61a1ae1ec858b34f8d9c9a7dc8894104 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 200 | 195 | 8 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 200 | 195 | 8 | 1003f0f417b015f0fe8ff71dd47449de22214d62 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 200 | 195 | 8 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 158 | 195 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 158 | 195 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.76e-06 | 163 | 195 | 7 | 4be3158f2a0ab460cfea8080a7370922910b5da9 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 169 | 195 | 7 | 3f8aa6d2f9aa060ae1a0ea3eb47e794099fc2c2c | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 169 | 195 | 7 | 26de495c7562e0740689d0f78e803698e3e793db | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 173 | 195 | 7 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 175 | 195 | 7 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 175 | 195 | 7 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 176 | 195 | 7 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 176 | 195 | 7 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 177 | 195 | 7 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 177 | 195 | 7 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.33e-05 | 177 | 195 | 7 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 179 | 195 | 7 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 180 | 195 | 7 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-05 | 180 | 195 | 7 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-05 | 182 | 195 | 7 | db5d6c5e7d59734653906b126f2c1d57461a5290 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.83e-05 | 186 | 195 | 7 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 186 | 195 | 7 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-05 | 186 | 195 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.83e-05 | 186 | 195 | 7 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-05 | 186 | 195 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-05 | 187 | 195 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 190 | 195 | 7 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | PSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.24e-05 | 192 | 195 | 7 | 8dbdaa6a81767a866fb856f99ae35f9ee8064106 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 192 | 195 | 7 | aa65557b35d3eba9f24b970849255d05174d1c05 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 192 | 195 | 7 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 192 | 195 | 7 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 2.32e-05 | 193 | 195 | 7 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 193 | 195 | 7 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.32e-05 | 193 | 195 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 194 | 195 | 7 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.40e-05 | 194 | 195 | 7 | b191851b2287afc8c47320f5488fd22e2a454aa6 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.40e-05 | 194 | 195 | 7 | c2ae2ea848d78725455dcb6be9f1d8933745fa80 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 194 | 195 | 7 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 195 | 195 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 195 | 195 | 7 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-05 | 195 | 195 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 2.56e-05 | 196 | 195 | 7 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-05 | 196 | 195 | 7 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 196 | 195 | 7 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| ToppCell | BLOOD--(3)_Non_classical_monocytes| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.56e-05 | 196 | 195 | 7 | b5ce99e27c9e87be52c10c022a665bf4df0e8b05 | |
| ToppCell | (7)_MNP-(7)_Monocyte|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.56e-05 | 196 | 195 | 7 | 4c2ea16352ba3482c02c03866460e0d975f9fc99 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD16_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.56e-05 | 196 | 195 | 7 | 83011b56780295dff5ded57064b07dcd2f19ea26 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 196 | 195 | 7 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-05 | 196 | 195 | 7 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-05 | 196 | 195 | 7 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 196 | 195 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 2.56e-05 | 196 | 195 | 7 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-05 | 197 | 195 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 197 | 195 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-05 | 197 | 195 | 7 | d9d58c2fe40d9b5b9031fb7a71525a535927effe | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.64e-05 | 197 | 195 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-05 | 197 | 195 | 7 | 8d6551e118cfe308088487c6d5171d986f90fb2f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 197 | 195 | 7 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 197 | 195 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 197 | 195 | 7 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 197 | 195 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-05 | 198 | 195 | 7 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.73e-05 | 198 | 195 | 7 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-05 | 198 | 195 | 7 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 2.73e-05 | 198 | 195 | 7 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.73e-05 | 198 | 195 | 7 | 1d92b09aeb03a95fa9e221813002045c4f41dd24 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-05 | 198 | 195 | 7 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 2.73e-05 | 198 | 195 | 7 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.73e-05 | 198 | 195 | 7 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | severe-Myeloid|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.73e-05 | 198 | 195 | 7 | d19902a6353445f9875dec59933b7553f5145b8b | |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.73e-05 | 198 | 195 | 7 | 4da73dc3acb29d70b160903600d2bf7fdab34333 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 198 | 195 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 2.73e-05 | 198 | 195 | 7 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 198 | 195 | 7 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | mild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.73e-05 | 198 | 195 | 7 | 908746384e10c6b833bb3bc124045d7b0bfd73b5 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-05 | 198 | 195 | 7 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | 2.73e-05 | 198 | 195 | 7 | ae0a51e63e2751a6d9dc0c8a3852680949173523 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-05 | 198 | 195 | 7 | 7d8fade2583c07a33dd83057cbce08e9fc77987a | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-05 | 198 | 195 | 7 | 165d60b111a17d517a420c434733eefb98da240d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 199 | 195 | 7 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.82e-05 | 199 | 195 | 7 | 2f9f75c2c7e00a855ce11411ff7b8271c9eec45f | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 199 | 195 | 7 | 37e3c00b127be4985843d8758c0ae0384f3bccfe | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 199 | 195 | 7 | 97888e2ae11178d1d526be1d7c518c51cffe976b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 199 | 195 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | COVID-19_Severe-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 2.82e-05 | 199 | 195 | 7 | e4d8bf016fd95a440e30014a75587e097e90cfad | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 199 | 195 | 7 | e22767758459deabefee2ea9d2b9b279cacfd015 | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.82e-05 | 199 | 195 | 7 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.82e-05 | 199 | 195 | 7 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 7.08e-06 | 197 | 192 | 10 | 5099_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | GABRG2 GPR50 ADAM23 CLSTN2 FZR1 CARD14 RALGPS2 NUP214 PAFAH2 MUC5AC | 7.40e-06 | 198 | 192 | 10 | 2623_UP |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A | ARHGAP32 GALK2 JADE3 NCDN FZR1 SUPT6H FN1 SCARB1 PAFAH2 PATJ | 7.40e-06 | 198 | 192 | 10 | 7204_DN |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | ABCC3 ADAM23 EXTL3 ZFYVE9 NPR1 ITGA10 NUP214 CRAT PAFAH2 SYMPK | 7.74e-06 | 199 | 192 | 10 | 2625_UP |
| Drug | manganese | GALK2 ITGAD ITGAX ZFYVE9 POLR1B CACNA1H CARD14 CACNA2D1 NPR1 FN1 B4GAT1 ITGA10 NUP214 INPP5F CRAT KRIT1 ACTR1B ACTR6 ADAT2 PCK1 | 1.29e-05 | 791 | 192 | 20 | CID000023930 |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.56e-06 | 5 | 189 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 4.08e-05 | 2 | 189 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | GALK2 BACE1 IRF1 TYK2 BMPR2 NUFIP2 OSBPL9 NR1H4 FN1 DNAH10 LMAN1L THADA SCARB1 DOCK7 SLC17A8 | 6.06e-05 | 713 | 189 | 15 | EFO_0005689 |
| Disease | hematologic cancer (implicated_via_orthology) | 7.06e-05 | 13 | 189 | 3 | DOID:2531 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 7.85e-05 | 215 | 189 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.14e-04 | 132 | 189 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | Endometrial Stromal Sarcoma | 4.03e-04 | 5 | 189 | 2 | C0206630 | |
| Disease | complement C4b measurement | 5.36e-04 | 25 | 189 | 3 | EFO_0008092 | |
| Disease | Schizophrenia | GABRG2 SETD1A ARHGAP32 GPR50 BACE1 ITIH3 NUFIP2 GRIN3A HSPA1A HSPA1B SLC17A6 NCS1 SH3PXD2A TNXB PCK1 | 5.99e-04 | 883 | 189 | 15 | C0036341 |
| Disease | Clear cell sarcoma of kidney | 6.02e-04 | 6 | 189 | 2 | C0334488 | |
| Disease | Lennox-Gastaut syndrome | 6.02e-04 | 6 | 189 | 2 | C0238111 | |
| Disease | EPILEPSY, CHILDHOOD ABSENCE, 1 | 6.02e-04 | 6 | 189 | 2 | C1838604 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 6.02e-04 | 6 | 189 | 2 | EFO_0802705 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 6.02e-04 | 6 | 189 | 2 | EFO_0801767 | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 6.02e-04 | 6 | 189 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 8.39e-04 | 7 | 189 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Walker-Warburg syndrome (implicated_via_orthology) | 8.39e-04 | 7 | 189 | 2 | DOID:0050560 (implicated_via_orthology) | |
| Disease | Abnormality of the eye | 8.39e-04 | 7 | 189 | 2 | C4316870 | |
| Disease | Major Depressive Disorder | 1.01e-03 | 243 | 189 | 7 | C1269683 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 1.11e-03 | 8 | 189 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | X-linked Adrenal Hypoplasia | 1.11e-03 | 8 | 189 | 2 | C0342482 | |
| Disease | muscular dystrophy-dystroglycanopathy type B1 (implicated_via_orthology) | 1.11e-03 | 8 | 189 | 2 | DOID:0050588 (implicated_via_orthology) | |
| Disease | Autistic behavior | 1.11e-03 | 8 | 189 | 2 | C0856975 | |
| Disease | lymphocyte count | PIK3AP1 EPPK1 IRF1 PLXND1 LYST CC2D2B TYK2 PTPRJ SUPV3L1 POLR1B HSPA1A HSPA1B FN1 DNAH10 SCML4 LMAN1L THADA SCARB1 CDA SP140 | 1.20e-03 | 1464 | 189 | 20 | EFO_0004587 |
| Disease | apolipoprotein B measurement | BACE1 NAGS NUFIP2 CACNA2D1 FN1 DNAH10 LMAN1L THADA SCARB1 DOCK7 STKLD1 SYMPK | 1.24e-03 | 663 | 189 | 12 | EFO_0004615 |
| Disease | Major depression, single episode | 1.43e-03 | 9 | 189 | 2 | C0024517 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.43e-03 | 9 | 189 | 2 | C3502809 | |
| Disease | Unipolar Depression | 1.46e-03 | 259 | 189 | 7 | C0041696 | |
| Disease | gluteofemoral adipose tissue measurement | 1.64e-03 | 132 | 189 | 5 | EFO_0803317 | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 2.15e-03 | 40 | 189 | 3 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | Shortened QT interval | 2.16e-03 | 11 | 189 | 2 | C0151879 | |
| Disease | cortical thickness | GALK2 PLXND1 ADGRV1 BTBD1 CHMP7 WNT3A DLEC1 RALGPS2 MSH3 LMAN1L ACTR1B THADA SH3PXD2A DOCK7 LRP4 EXOC4 | 2.25e-03 | 1113 | 189 | 16 | EFO_0004840 |
| Disease | psoriatic arthritis | 2.40e-03 | 87 | 189 | 4 | EFO_0003778 | |
| Disease | Congenital muscular dystrophy | 2.58e-03 | 12 | 189 | 2 | cv:C0699743 | |
| Disease | Crohn's disease of large bowel | 2.82e-03 | 44 | 189 | 3 | C0156147 | |
| Disease | IIeocolitis | 2.82e-03 | 44 | 189 | 3 | C0949272 | |
| Disease | Crohn's disease of the ileum | 2.82e-03 | 44 | 189 | 3 | C0267380 | |
| Disease | Regional enteritis | 2.82e-03 | 44 | 189 | 3 | C0678202 | |
| Disease | multiple sclerosis symptom measurement | 3.21e-03 | 46 | 189 | 3 | EFO_0803536 | |
| Disease | glucose measurement | 3.25e-03 | 380 | 189 | 8 | EFO_0004468 | |
| Disease | Squamous cell carcinoma of esophagus | 3.30e-03 | 95 | 189 | 4 | C0279626 | |
| Disease | apolipoprotein A 1 measurement | OR5T1 BACE1 FZR1 BMPR2 DLEC1 TANGO6 DNAH10 ITGA10 ERLIN1 SCARB1 DOCK7 CDA NNT | 3.36e-03 | 848 | 189 | 13 | EFO_0004614 |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 3.53e-03 | 14 | 189 | 2 | C1836373 | |
| Disease | alpha-Dystroglycanopathies | 3.53e-03 | 14 | 189 | 2 | C2936406 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 3.53e-03 | 14 | 189 | 2 | C0410174 | |
| Disease | Muscle eye brain disease | 3.53e-03 | 14 | 189 | 2 | C0457133 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 3.53e-03 | 14 | 189 | 2 | C4284790 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 MED14 BMPR2 SPATA21 DLEC1 HSPA1B SLC17A6 FN1 B4GAT1 POLH DGKE NUP214 ARAP3 CDA CUX1 | 4.00e-03 | 1074 | 189 | 15 | C0006142 |
| Disease | Walker-Warburg congenital muscular dystrophy | 4.06e-03 | 15 | 189 | 2 | C0265221 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 4.06e-03 | 15 | 189 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Crohn Disease | 4.06e-03 | 50 | 189 | 3 | C0010346 | |
| Disease | multiple sclerosis | SETD1A EPPK1 PRR5L TMEM8B IRF1 CLSTN2 TYK2 SLC15A2 IQCB1 SP140 | 5.16e-03 | 594 | 189 | 10 | MONDO_0005301 |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 5.21e-03 | 17 | 189 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | triglycerides in medium VLDL measurement | 5.31e-03 | 55 | 189 | 3 | EFO_0022155 | |
| Disease | melanoma | 5.41e-03 | 248 | 189 | 6 | C0025202 | |
| Disease | Ciliopathies | 5.55e-03 | 110 | 189 | 4 | C4277690 | |
| Disease | triglycerides in large VLDL measurement | 5.59e-03 | 56 | 189 | 3 | EFO_0022178 | |
| Disease | systemic lupus erythematosus | IRF1 IRF7 FAM98B ITGAX LYST MYO5C TYK2 HSPA1A HSPA1B RALGPS2 IQCB1 TNXB | 5.60e-03 | 799 | 189 | 12 | MONDO_0007915 |
| Disease | Colorectal Carcinoma | ABCC3 CLSTN2 NCDN KMT2C FN1 ARAP3 STRAP TNS4 CDH7 CUX1 EXOC4 | 5.80e-03 | 702 | 189 | 11 | C0009402 |
| Disease | systemic lupus erythematosus, COVID-19 | 6.16e-03 | 58 | 189 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | mean platelet volume | ARHGAP32 GALK2 SETD1B BACE1 PLXND1 ACSL1 ST3GAL6 PTPRJ ZNF584 BTBD2 LRRC8D DOCK7 NNT CUX1 | 6.23e-03 | 1020 | 189 | 14 | EFO_0004584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLVDIYPTMLDIAGI | 356 | Q6UWY0 | |
| DIGIQEMGIPEAIVY | 286 | Q9GZN1 | |
| EMGIPEAIVYSIQNL | 291 | Q9GZN1 | |
| FPVISLYLMGEVTNQ | 341 | P56817 | |
| GIPISILVMVLVDYS | 931 | P48751 | |
| EPNYEALISIQIGIM | 1536 | Q8NDM7 | |
| DFQVIYRGMELIPTI | 1096 | Q4VNC0 | |
| VNEYGLPMAVAQVLS | 416 | O75077 | |
| ALENTEVPVGCLMVY | 36 | Q7Z6V5 | |
| AGDLIMEVYIEQQLP | 1116 | Q8WWN8 | |
| VSTGDPEMVQLVLQY | 81 | Q6ZTN6 | |
| NYALVIDVDMVPSEG | 221 | O43505 | |
| EEDPVLTVITYMGLS | 531 | Q9UHX3 | |
| QIYPGSIELMQVIED | 666 | O60242 | |
| SMVIVPLYDTLGNEA | 171 | P33121 | |
| IQELVAMSPELDTYG | 1116 | P39880 | |
| EVLMNTYSVVQLPEE | 381 | Q8WXI3 | |
| IEVVNMLAPYAVFDI | 91 | O75477 | |
| SYQIEILASDMGVPQ | 961 | Q6V0I7 | |
| MESYDIIANQPVVID | 1 | P42025 | |
| GMPALIVAVSAAVDY | 976 | Q9HAR2 | |
| LEAQVGLDYIFTPMI | 3001 | Q8WXG9 | |
| VMIDNETLPVEYLGG | 151 | P43155 | |
| PMNEAAYLEVSVVLD | 306 | Q5VUY0 | |
| ETIGDAYMVVSGLPV | 921 | P16066 | |
| GIQEIVAMSPELDTY | 1036 | O14529 | |
| ISIPEVDAYVMVLQA | 616 | Q9H4D0 | |
| VDAYVMVLQAIEPRI | 621 | Q9H4D0 | |
| VPAATEDLYVEMLQA | 451 | Q6ZUJ8 | |
| IQMPYIDVQSIIDAV | 1381 | Q6DHV5 | |
| PMAVVATAERGLIVY | 181 | P78406 | |
| VMQVIYTDDAGRPQT | 636 | O43374 | |
| YPTNMEELVTVDEVG | 901 | Q5T481 | |
| IGIELTDSPYVVASM | 156 | P35558 | |
| VMQVIYTDDAGRPQT | 636 | C9J798 | |
| NIETVVVADPAMVSY | 326 | Q8TE59 | |
| DVIPMADAAGIIRYA | 271 | P20702 | |
| VPGYMQDLEVEQALT | 166 | P10914 | |
| IIVLADGQVSEMGPY | 821 | O15438 | |
| MPAETLYQGETEVAE | 101 | Q96RI1 | |
| DGMISTINPVDAIYQ | 191 | Q96SU4 | |
| VAFVPLGMTDYLVIV | 126 | P16234 | |
| EENVGIDITEPLYMQ | 181 | P33991 | |
| LITIMAQIGSYVPAE | 911 | P20585 | |
| AQEMPTVSVLEYALP | 141 | Q86TB9 | |
| YGDITVAMTSEIVLP | 1161 | Q12913 | |
| ADDMIVYLENPIVSA | 701 | O00370 | |
| ISEIYAPATLPVMQE | 371 | Q6P499 | |
| GEMATVAPVLYTNIN | 1646 | Q8NEZ4 | |
| VMEEVVITPPYQVEN | 136 | Q3MHD2 | |
| GLAMFASYVPEIIEL | 376 | Q12791 | |
| DAIYQMVGNTVELPE | 126 | P62166 | |
| PEMVAAYQGVLVELA | 681 | Q9UBB6 | |
| MAAEAQVSYLPVGIE | 406 | Q9HAT1 | |
| SYLEINIPMTVEENG | 416 | Q2LD37 | |
| TVLAVLPNMYIGTIE | 156 | Q13585 | |
| PNVVVTEAVMAPVYD | 931 | Q86SJ6 | |
| TEAVMAPVYDIQGNI | 936 | Q86SJ6 | |
| MAVPGEAEEEATVYL | 1 | Q96I76 | |
| PGVLIQVYEGERAMT | 436 | P0DMV9 | |
| DVRQEYPGMILQISG | 611 | Q9Y4D7 | |
| VTVALVMQIYFGDPQ | 121 | Q9UJ14 | |
| YSVLPMAVEQDVLIA | 56 | Q01415 | |
| YVPMNEQIVIGRLDE | 31 | Q9UM44 | |
| ISQPTIVEALLGYEM | 431 | Q86SG6 | |
| LPMGVVVDYTNQVEI | 361 | P35658 | |
| GIVLESQMVLPVIYE | 1201 | P50748 | |
| MGNPENIEDAYVAVI | 1 | O00522 | |
| DPLNILMAGQIYDTV | 311 | Q6PI73 | |
| DPLNILMAGQIYDTV | 311 | O75022 | |
| SEGYNAAAILTMEPV | 421 | Q8N159 | |
| DESQEVPYTIRQMGI | 986 | P98088 | |
| VQEPSPGALDVTIMY | 281 | Q92985 | |
| MTPAVQDDLGGIYVI | 1776 | A7KAX9 | |
| TQQPYTDGVRMEEIV | 546 | P14923 | |
| VMNELSGSDNVPYVV | 181 | Q27J81 | |
| VSIIVPIIYDMASGT | 1381 | O60244 | |
| LLPYNLSLEVVMAIE | 141 | Q8TCU5 | |
| EMVLTPLTEQEGEAY | 266 | Q6MZQ0 | |
| LQLMPQVGYESTAEI | 161 | Q5T6X5 | |
| VLEEDEVYNAIPIIM | 1091 | Q13349 | |
| EVYNAIPIIMGSSVG | 1096 | Q13349 | |
| AGALSVPMAYQIVLE | 111 | Q9Y6A1 | |
| DNDMIVSIFYTIVIP | 281 | Q8NG75 | |
| VLYLAMSPDGEAIVT | 446 | Q9UM11 | |
| IVANVESMDYDPLVV | 801 | Q96A65 | |
| DALDQLRGAVMIVYP | 141 | P57076 | |
| PGTQIVMVDYEASEP | 611 | Q9BXL6 | |
| IGIIMETVPQLYDFT | 1246 | Q96N67 | |
| CVMEQLDVGIVPYIV | 1171 | O14981 | |
| IAGYVSQPMVDVSIL | 176 | Q96JJ3 | |
| INTQEYLDVLGRPMV | 421 | P54289 | |
| APEINVVVYIGDLMS | 556 | O14647 | |
| TEMTIEGLQPTVEYV | 1686 | P02751 | |
| VSPVNDVDVGVYQLM | 231 | Q8WUX9 | |
| CLYVILVGEMQEPVV | 236 | O43909 | |
| LYSDEVQIGPETVMT | 136 | Q9H0C5 | |
| IGPVNAINMEYTIDI | 101 | P18507 | |
| EVGTIRYMAPEVLEG | 376 | Q13873 | |
| LEAGMYDVPIIVTDS | 681 | P55283 | |
| VYQEVQAMFDTLGIP | 146 | Q52LJ0 | |
| FQPYPMEDITVVITL | 1686 | Q0VDD8 | |
| LTQGEIIYPEICMLE | 1261 | Q99698 | |
| PTEFEVVLYLNQMGV | 71 | Q9Y586 | |
| MDVVIVLDGSNSIYP | 166 | O75578 | |
| QLVGLLSPMVYQEVE | 276 | Q15051 | |
| YDPEGILGTINSIVM | 496 | Q68CP4 | |
| MEVYEDTPVGTIIGA | 391 | P55289 | |
| EVGVIESPLMYEDSI | 126 | P32881 | |
| VLELPYQGEELSMVI | 216 | P30740 | |
| NVTVQMEPTEAYEVL | 676 | Q9Y678 | |
| VMVLAGVTDPEYQDE | 51 | Q6ZN92 | |
| PGVLIQVYEGERAMT | 436 | P0DMV8 | |
| LYPMEVSEATQVGNI | 381 | Q9ULB5 | |
| YAGEIPVAQVLRNVM | 326 | P52429 | |
| PMAGILAYTEDEVVS | 341 | O14556 | |
| DEVQIGPETVMTTLY | 181 | Q9BX70 | |
| RPLQEVEMETYGAGT | 1946 | O95180 | |
| IGPVYEMVIALQNTT | 386 | Q9Y238 | |
| EIMPETLEYGIINAN | 121 | Q8IVF4 | |
| PYLMDVIVEGIVDGR | 2286 | Q8IVF4 | |
| DGIVRIYEAPDVMNL | 136 | Q96EE3 | |
| PINALQAAMEGYEVT | 246 | P23526 | |
| QLPQYALVTAGEVMF | 611 | Q16348 | |
| AYRQAVIDLMQGIPV | 556 | Q9Y2H2 | |
| VIDLMQGIPVTEDLY | 561 | Q9Y2H2 | |
| MAIVVAYVPEGLLAT | 336 | P20648 | |
| RMQEPGQIVETYTEE | 101 | O60716 | |
| YVVAMETFTNLGPIV | 346 | Q16531 | |
| TEPGYINIMELAASV | 121 | Q92613 | |
| VLDPEFMVQLLTGVY | 231 | Q8IXS8 | |
| VSYNNISMIPIEIGL | 736 | Q7L1W4 | |
| TRGSLDPYEGQEVMV | 336 | Q99487 | |
| EEYAGQITLMDVPVF | 51 | Q86X27 | |
| PGVLIQVYEGERAMT | 436 | P11142 | |
| YGVLDTNIENMELTP | 156 | Q8TBP5 | |
| PDVGAQEEPVYIEMV | 206 | Q6ZVC0 | |
| VVQEYVDIMEELLGP | 516 | Q8IVF1 | |
| VVQEYVDIMEELLGP | 516 | A6NNL0 | |
| VVQEYVDIMEELLGP | 516 | B1AL46 | |
| LGTPMLIEDGYAVTQ | 266 | Q15406 | |
| AMDQVPRVTIAQGYD | 176 | Q13423 | |
| TEEYRVPDGMVGLII | 146 | Q92945 | |
| ILEVMGDQSLVPYAS | 481 | Q6YHU6 | |
| MLALPEAVLEEITNY | 321 | Q7Z572 | |
| PTEFEVVLYLNQMGV | 71 | Q13394 | |
| YFSLMPVVTEDLVGI | 421 | Q7RTX9 | |
| APQQYIVVTVSEGAM | 96 | P22670 | |
| PDAGYAVQMSVEESL | 781 | O95486 | |
| LLTGVEMEYPENAIL | 471 | Q06033 | |
| PVAIQRGYVDQEMET | 1061 | P58107 | |
| EALGIVPLQYVFVMT | 531 | Q9NUX5 | |
| IDSYDVIIRMNNGPV | 136 | Q9Y274 | |
| LVALVMAYSFQEPLE | 216 | Q8TBK2 | |
| LLTYVMEEEGQTLPG | 551 | Q8NDZ2 | |
| SDYIVMPNILVLGAA | 131 | Q8WTV0 | |
| PIAADEMVIEYVGQN | 1846 | Q9UPS6 | |
| VIEILGIEYMGELTQ | 266 | Q9Y253 | |
| VTTPYEVAVIDEIQM | 281 | Q8IYB8 | |
| DEFIDVIVGNRVYMP | 226 | P55039 | |
| AVEVLVAGVRMIYPA | 266 | Q9UHV7 | |
| VCSGGEPVYIVTELM | 291 | Q9H3Y6 | |
| MVDGVQVALPSYEEA | 166 | Q92537 | |
| DVVPTMAQGVIEYKE | 121 | Q15120 | |
| EPIAADEMVIEYVGQ | 1586 | O15047 | |
| TSGYPLQEVVDDEML | 36 | A6NHP3 | |
| VSSMEYIPEGEILVI | 186 | Q9Y3F4 | |
| DGTYIVMTVQELLPS | 121 | P32320 | |
| SELPYVLEMVAELAG | 526 | Q96EP0 | |
| LYAVSMAPAPEQIVT | 1586 | Q9BXT8 | |
| PEAVLEGARYMVALQ | 581 | Q7KZ85 | |
| AVIAMPLAGILVQYT | 226 | Q9P2U8 | |
| PQTYEVELEMQASGL | 1556 | Q7Z2Z1 | |
| VMEVTFQGEYPATLV | 531 | Q7Z417 | |
| LISQVLATYPADGEM | 506 | Q8NE28 | |
| MPSAIEAIYIILIAG | 1 | Q9NYW1 | |
| EYDMVQPASQVIGLV | 691 | Q8IZW8 | |
| GPDYEVMVATLDTQI | 536 | Q8NI35 | |
| ATAEPMILEQYVVVS | 161 | Q5TCZ1 | |
| TSGYPLQEVVDDEML | 36 | Q495Y8 | |
| TSGYPLQEVVDDEML | 36 | P0CI01 | |
| YMEQEVIGPDGIITV | 186 | Q9HAT0 | |
| MPAVIGFQTAEVDLL | 381 | Q6UWL2 | |
| EVDIGYIPQMELEAT | 356 | Q9NZV5 | |
| TVGNVPDVYTQIMLL | 146 | Q8N0X2 | |
| TDLMPGVEYVVTVTA | 896 | P22105 | |
| YVVGNEPLTVLMDSL | 461 | Q9C0B7 | |
| PGIVVFCIMDYDVLQ | 281 | A6NDV4 | |
| VANLVLISMVYLPEA | 411 | Q92797 | |
| VGYQVPEAEVVMLEQ | 66 | Q6P3V2 | |
| MLEYFGVPVEQVLLI | 11 | Q6P444 | |
| AVPTELALLYMIENG | 141 | Q96HH6 | |
| CRNYVEIMPSVAEGI | 56 | P56704 | |
| LLPYDTEVLESNGMI | 241 | Q13342 | |
| LTEQGFVEYAVLMPS | 581 | Q9Y4F4 | |
| DMDNYPIGTNAIVAV | 731 | Q9H9Y6 | |
| PSLQGLVMFEDVTVY | 11 | Q8IVC4 | |
| VTTEEYLVNPVGMNR | 231 | Q8N228 | |
| TMVIYTPQERFEIGQ | 451 | P51854 | |
| DVYLVEGEQVLMPIT | 286 | P35125 | |
| QLSEGPVVMELIFYI | 1406 | O95405 | |
| AVVAMPLAGVLVQYI | 231 | Q8NDX2 | |
| VCVRGPENIMVTEYV | 676 | P29597 | |
| IPYFADVVVPINITM | 1066 | O75096 | |
| IIVPGMLEYESLQGI | 1511 | Q9NQX4 |